Hospital
Father Flanagan's Boys' Home
Father Flanagan's Boys' Home was paid $16.16M by Medicaid between Jan 2018 and Nov 2024, across 110 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 45% of everything it billed.
33Billing provider infoFATHER FLANAGAN'S BOYS' HOME
OMAHA, NE 68131
OMAHA, NE 68131
33aNPI1457458556assigned 09/20/2006
33bProvider typeChildren's Hospital
28Total paid$16.16M
24GClaims178,442
24DCodes billed110
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,456 | $2.06M | |
| 2019 | 27,464 | $2.05M | |
| 2020 | 19,825 | $2.25M | |
| 2021 | 38,426 | $3.37M | |
| 2022 | 35,804 | $3.41M | |
| 2023 | 25,663 | $2.37M | |
| 2024incomplete | 9,804 | $637K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 45% | 4,216 | 3,878 | $7.23M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 20% | 1,892 | 1,839 | $3.15M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 11% | 2,117 | 1,958 | $1.75M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 3.4% | 753 | 700 | $555K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.6% | 2,237 | 2,066 | $422K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 6,347 | 6,244 | $320K |
| 42830 | 2.0% | 147 | 144 | $317K | |
| 95812 | 1.8% | 443 | 437 | $297K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1.3% | 326 | 308 | $206K |
| G0378 | Hospital observation service, per hour | <1% | 946 | 846 | $116K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,720 | 2,640 | $114K |
| 80050 | General health panel | <1% | 3,909 | 3,838 | $110K |
98 more codes
| 74018 | <1% | 1,287 | $89K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,928 | $76K |
| J3490 | Unclassified drugs | <1% | 24,665 | $76K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 8,879 | $74K |
| 84439 | <1% | 4,041 | $68K | |
| 83655 | <1% | 3,699 | $64K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,106 | $63K |
| 70310 | <1% | 2,358 | $62K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 9,863 | $58K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 843 | $55K |
| 92586 | <1% | 371 | $51K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 10,218 | $47K |
| 80061 | Lipid panel | <1% | 3,592 | $46K |
| 88342 | <1% | 1,777 | $45K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,922 | $42K |
| 95716 | <1% | 59 | $40K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 109 | $36K |
| 86140 | <1% | 3,410 | $35K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,190 | $31K |
| 87632 | <1% | 145 | $31K | |
| 45331 | <1% | 71 | $29K | |
| 87507 | <1% | 61 | $26K | |
| 92585 | <1% | 76 | $26K | |
| 85027 | <1% | 3,425 | $26K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 28 | $24K |
| 82728 | <1% | 1,484 | $22K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,574 | $22K |
| 82784 | <1% | 2,127 | $21K | |
| 95700 | <1% | 47 | $19K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 954 | $17K |
| 85652 | <1% | 3,080 | $16K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 5,555 | $16K |
| 73562 | <1% | 174 | $15K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,121 | $14K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,792 | $13K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 127 | $12K |
| 82247 | <1% | 1,703 | $11K | |
| A4649 | Surgical supply; miscellaneous | <1% | 835 | $10K |
| 73630 | <1% | 106 | $10K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 184 | $10K |
| 95813 | <1% | 12 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 975 | $10K |
| 82248 | <1% | 1,695 | $9K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,310 | $8K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 29 | $7K |
| 83540 | <1% | 929 | $6K | |
| 73610 | <1% | 70 | $6K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 69 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 184 | $5K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 784 | $5K |
| 80306 | <1% | 280 | $5K | |
| 83690 | <1% | 695 | $4K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 13 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,250 | $4K |
| 81025 | <1% | 1,129 | $4K | |
| 84703 | <1% | 501 | $3K | |
| 85651 | <1% | 777 | $3K | |
| 81003 | <1% | 839 | $3K | |
| 82657 | <1% | 236 | $2K | |
| S1015 | Iv tubing extension set | <1% | 512 | $2K |
| 83550 | <1% | 187 | $2K | |
| 82607 | <1% | 93 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 80 | $2K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 91 | $2K |
| A7002 | Tubing, used with suction pump, each | <1% | 350 | $2K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 41 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 151 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 115 | $1K |
| A4624 | Tracheal suction catheter, any type other than closed system, each | <1% | 221 | $1K |
| A4930 | Gloves, sterile, per pair | <1% | 441 | $1K |
| 83516 | <1% | 97 | $737.27 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 31 | $694.89 |
| 70320 | <1% | 215 | $659.94 | |
| J2704 | Injection, propofol, 10 mg | <1% | 7,757 | $545.82 |
| A4231 | Infusion set for external insulin pump, needle type | <1% | 502 | $378.82 |
| 83525 | <1% | 12 | $248.92 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 79 | $238.69 |
| 85610 | <1% | 38 | $231.76 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 32 | $185.55 |
| 86364 | <1% | 171 | $179.31 | |
| 82550 | <1% | 28 | $170.00 | |
| 83735 | <1% | 29 | $162.86 | |
| 85018 | <1% | 13 | $153.36 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 252 | $143.26 |
| A4218 | Sterile saline or water, metered dose dispenser, 10 ml | <1% | 85 | $106.88 |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 15 | $105.17 |
| 87070 | <1% | 15 | $61.25 | |
| 85007 | <1% | 13 | $56.50 | |
| 87205 | <1% | 13 | $30.62 | |
| 3044F | <1% | 50 | $0.01 | |
| A4248 | Chlorhexidine containing antiseptic, 1 ml | 0% | 19 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 17 | $0.00 |
| C9285 | Lidocaine 70 mg/tetracaine 70 mg, per patch | 0% | 310 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 106 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 287 | $0.00 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 129 | $0.00 |
| A9150 | Non-prescription drugs | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRENBARGER, BRIDGETTE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Father Flanagan's Boys' Home | Omaha, NE | $23.20M |
| Father Flanagan's Boys Home | Boys Town, NE | $2.98M |
| Father Flanagan's Boys Home | Grand Island, NE | $263K |
| Father Flanagan's Boys Home | Omaha, NE | $77K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.